Global High-Throughput Screening Market

The global High-Throughput Screening Market was valued at USD 12.95 billion in 2016 and is projected to reach USD 25.38 billion by 2025, growing at a CAGR of 7.76% from 2017 to 2025.
High Throughput Screening (HTS) is a drug-discovery process widely used in the pharmaceutical industry. It leverages automation to quickly assay the biological or biochemical activity of a large number of drug-like compounds.

Sample Infographics:



Market Dynamics:
1. Market Drivers
1.1 Growing Adoption of Open Innovation Models in Pharmaceutical and Biotechnology Companies
1.2 Rising Government Funding
1.3 Increasing R&D Spending
1.4 Technological Advancements

2. Market Restraints
2.1 Capital Intensive Nature of HTS
2.2 Complexities in the field of Assay Development
Market Segmentation:
1. Global High-Throughput Screening Market, by End User:
1.1 Pharmaceutical and Biotechnology Companies
1.2 Academic and Government Research Institutes
1.3 Contract Research Organizations
1.4 Other End Users

2. Global High-Throughput Screening Market, by Application:
2.1 Target Identification
2.2 Primary Screening
2.3 Toxicology Assessment
2.4 Other Applications

3. Global High-Throughput Screening Market, by Product and Service:
3.1 Consumables & Reagents
3.2 Instruments
3.3 Software & Services

4. Global High-Throughput Screening Market, by Technology:
4.1 Cell-Based Assays
4.1.1 2D Cell Culture
4.1.2 3D Cell Culture
4.1.2.1 Scaffold-Based Technology
4.1.2.1.1 Hydrogels
4.1.2.1.1.1 Animal-Derived Hydrogels
4.1.2.1.1.2 Alginate/Agarose
4.1.2.1.1.3 Synthetic Hydrogels
4.1.2.1.2 Inert Matrix/Solid Scaffolds
4.1.2.2 Scaffold-Free Technology
4.1.2.2.1 Microplates
4.1.2.2.2 Hanging-Drop Plates
4.1.2.2.3 Ultra-Low Binding Plates
4.1.2.2.4 Other Scaffold-Free Technologies
4.1.3 Perfusion Cell Culture
4.2 Lab-On-A-Chip
4.3 Ultra-High-Throughput Screening
4.4 Label-Free Technology
4.5 Bioinformatics

5. Global High-Throughput Screening Market, by Region:
5.1 North America (U.S., Canada, Mexico)
5.2 Europe (Germany, UK, France, Rest of Europe)
5.3 Asia Pacific (China, India, Japan, Rest of Asia Pacific)
5.4 Latin America (Brazil, Argentina, Rest of Latin America)
5.5 Middle East & Africa

Competitive Landscape:
The major players in the market are as follows:
1. Agilent Technologies, Inc.
2. Danaher Corporation
3. Perkinelmer, Inc.
4. Thermo Fisher Scientific Inc.
5. Axxam S.P.A.
6. Tecan Group Ltd.
7. Bio-Rad Laboratories, Inc.
8. Hamilton Company
9. Sigma-Aldrich Corporation (A Division of Merck Millipore)
10. Aurora Biomed, Inc.
These major players have adopted various organic as well as inorganic growth strategies such as mergers & acquisitions, new product launches, expansions, agreements, joint ventures, partnerships, and others to strengthen their position in this market.

RESEARCH METHODOLOGY OF VERIFIED MARKET INTELLIGENCE:
Research study on the High-Throughput ScreeningMarketwas performed in five phases which include Secondary research, Primary research, subject matter expert advice, quality check and final review.
The market data was analyzed and forecasted using market statistical and coherent models. Also market shares and key trends were taken into consideration while making the report. Apart from this, other data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Top to Bottom Analysis and Vendor Share Analysis.

To know more about the Research Methodology of Verified Market Intelligence and other aspects of the research study, kindly get in touch with our sales team.